PAVmed (PAVM) Gross Profit (2021 - 2025)

PAVmed's (PAVM) quarterly Gross Profit came in at -$4000.0 in Q4 2025, up 89.47% year-on-year from -$2111.1 in Q4 2024, and up 92.0% quarter-over-quarter from -$50000.0 in Q3 2025.

PAVmed (PAVM) Gross Profit (2021 - 2025) Analysis & Trends

PAVmed's Gross Profit history runs 5 years deep, the most recent figure standing at -$4000.0 for Q4 2025.

  • On a quarterly basis, Gross Profit rose 89.47% year-over-year to -$4000.0 in Q4 2025; TTM through Dec 2025 was -$117000.0, a 94.21% increase from a year earlier, with the FY2025 full-year figure at -$118000.0, up 93.6% from the prior year.
  • Gross Profit advanced to -$4000.0 in Q4 2025 per PAVM's latest filing, from -$50000.0 in the prior quarter.
  • Across five years, Gross Profit topped out at $56000.0 in Q3 2021 and bottomed at -$1.5 million in Q3 2022.
  • The 5-year median for Gross Profit is -$371000.0 (2022), against an average of -$554125.0.
  • Across the five-year window, Gross Profit plunged 2867.86% in 2022 and surged 96.19% in 2025, its largest moves.
  • Year by year, Gross Profit stood at -$141000.0 in 2021, then sank by 968.09% to -$1.5 million in 2022, then surged by 62.68% to -$562000.0 in 2023, then soared by 93.24% to -$38000.0 in 2024, then jumped by 89.47% to -$4000.0 in 2025.
  • Per Business Quant, the three latest PAVM Gross Profit figures stand at -$4000.0 (Q4 2025), -$50000.0 (Q3 2025), and -$35000.0 (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 PAVmed 9.85 Mn -3.35 Mn -4,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -4,000.00
Dec 31, 2025 -4,000.00
Sep 30, 2025 -50,000.00
Sep 30, 2025 -50,000.00
Jun 30, 2025 -35,000.00
Jun 30, 2025 -35,000.00
Mar 31, 2025 -28,000.00
Mar 31, 2025 -28,000.00
Dec 31, 2024 -38,000.00
Dec 31, 2024 -38,000.00
Jun 30, 2024 -687,000.00
Jun 30, 2024 -687,000.00
Mar 31, 2024 -734,000.00
Mar 31, 2024 -734,000.00
Dec 31, 2023 -562,000.00
Dec 31, 2023 -562,000.00
Sep 30, 2023 -988,000.00
Sep 30, 2023 -988,000.00
Jun 30, 2023 -1.52 Mn
Jun 30, 2023 -1.52 Mn